CropDesign N.V.
(CropDesign) and Plant
Bioscience Ltd. (PBL) announced today that they have signed
a broad licence agreement concerning the PBL’s AMPLICON,
AMPLICON-PLUS, and related technologies for application in
protein over-expression in plants. Under the terms of the
agreement, CropDesign has exclusive worldwide rights to AMPLICON
and AMPLICON-PLUS for the production of industrial-type enzymes
and proteins in plants. In addition, CropDesign is granted
non-exclusive rights to the technologies in the area of
production of pharmaceutical products in plants.
AMPLICON is a gene silencing technology developed at the
Sainsbury Laboratory (Norwich, UK) by Professor David Baulcombe.
AMPLICON-PLUS, developed by Professor Vicki Vance and colleagues
at the University of South Carolina, is a method for achieving
hyper-expression of transgenes in plants. The result of
combining both these technologies is extremely high and uniform
levels of transgene over-expression.
According to Dr. Herman Van Mellaert, CropDesign CEO, "With
the licence on AMPLICON and AMPLICON-PLUS we are now well
positioned to gain additional leverage from the TraitMill in
this new business area. This technology will enable us to
rapidly and effectively develop rice lines producing large
amounts of recombinant proteins for our partners." CropDesign’s
core technology platform is the rice TraitMill, an integrated
high-throughput system for gene cloning, plant transformation
and plant evaluation. TraitMill is designed to deliver improved
agronomic traits directly in cereal crops. Van Mellaert added,
"Not only is rice a key target for agronomic improvement, it is
also ideally suited for cost-effective and environmentally safe
molecular farming. The market requires such effective production
tools to bring new biotech-based proteins and drugs to market."
Dr. Jan Chojecki, Managing Director of PBL, commented that,
"We are very pleased to have had this further endorsement for
our technology by CropDesign. We fully expect that AMPLICON and
AMPLICON-PLUS will prove to be of considerable value to their
product development programs. Novel gene expression technologies
are critical for production of new generations of enzymes and
other proteins".
CropDesign, based in Gent, Belgium is an agbiotech company
focussed on the application of functional genomics for improved
crop performance, including higher yield, heightened tolerance
to stress and diseases and better quality. The company also
applies its technology in other business areas, including
molecular farming. CropDesign applies its technology in rice,
wheat and other cereals. Founded in 1998, CropDesign employs
over 65 people at its research facilities in Gent.
PBL, based in Norwich, UK is an independent technology
management company specializing in plant and microbial sciences.
The company manages and commercializes research conducted by
leading plant and microbial science laboratories around the
world.